🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Midazolam - Medicines in Ireland

23 authorised products containing Midazolam, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 23 authorised medicines
MedicineActive substanceLicence holderStatus
BUCCOLAM 10 mg oromucosal solution
EU/1/11/709/004
Midazolam Laboratorios Lesvi, S.L.
BUCCOLAM 2.5 mg oromucosal solution
EU/1/11/709/001
Midazolam Laboratorios Lesvi, S.L.
BUCCOLAM 5 mg oromucosal solution
EU/1/11/709/002
Midazolam Laboratorios Lesvi, S.L.
BUCCOLAM 7.5 mg oromucosal solution
EU/1/11/709/003
Midazolam Laboratorios Lesvi, S.L.
Epistatus 10 mg oromucosal solution
PA20595/002/001
Midazolam SERB S.A. Not marketed
Epistatus 2.5 mg oromucosal solution
PA20595/002/002
Midazolam SERB S.A. Not marketed
Epistatus 5 mg oromucosal solution
PA20595/002/003
Midazolam SERB S.A. Not marketed
Epistatus 7.5 mg oromucosal solution
PA20595/002/004
Midazolam SERB S.A. Not marketed
Midazolam 1 mg/ml solution for injection in pre-filled syringe
PA1968/017/001
Midazolam Laboratoire Aguettant Marketed
Midazolam 1 mg/ml Solution for Injection or Infusion
PA2315/063/001
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 1 mg/ml solution for injection/infusion
PA2165/012/002
Midazolam AS Kalceks
Midazolam 1 mg/ml solution for injection/infusion
PA1968/017/002
Midazolam Laboratoire Aguettant Marketed
Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe
PA2315/220/001
Midazolam Accord Healthcare Ireland Ltd. Not marketed
Midazolam 2 mg/ml Solution for injection or infusion
PA2315/063/005
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 5 mg/ml Solution for injection or infusion
PA2315/063/006
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 5 mg/ml Solution for Injection or Infusion
PA2315/063/002
Midazolam Accord Healthcare Ireland Ltd. Not marketed
Midazolam 5 mg/ml solution for injection/infusion
PA2165/012/001
Midazolam AS Kalceks
Midazolam 5 mg/ml solution for injection/infusion
PA1968/017/003
Midazolam Laboratoire Aguettant Marketed
Midazolam Rowa 10 mg oromucosal solution
PA0074/099/004
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 2.5 mg oromucosal solution
PA0074/099/001
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 5 mg oromucosal solution
PA0074/099/002
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 7.5 mg oromucosal solution
PA0074/099/003
Midazolam Rowa Pharmaceuticals Limited, Marketed
Ozalin 2 mg/ml oral solution in single-dose container
PA25340/002/001
Midazolam Istituto Gentili S.r.l. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.